Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020

NEXT STORY
CB2 Insights Announces Q1 Financial Statements to be filed on or before July 14, 2020
PREV STORY
Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CRISPR-Focused Excision BioTherapeutics Announces Business Advisory Board and Addition of Interim Chief Business Officer

author_avatar
NASDAQ Market News

Eurobio Scientific launches its COVID antigen self-test

author_avatar
NASDAQ Market News

AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

author_avatar
NASDAQ Market News